Congenital Fiber-Type Disproportion

Seminars in Pediatric Neurology

Volumn 18, Issue 4, 2011, Pages 264-271

  Clarke, Nigel F ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTIN; ALPHA TROPOMYOSIN; BETA MYOSIN; BETA TROPOMYOSIN; CALCIUM; MYOSIN; RYANODINE RECEPTOR; TROPOMYOSIN; UNCLASSIFIED DRUG; VITAMIN D;

ACTA1 GENE; AEROBIC EXERCISE; ARTICLE; AUTOSOMAL RECESSIVE INHERITANCE; BONE DENSITY; CARDIOMYOPATHY; CLINICAL FEATURE; CONGENITAL FIBER TYPE DISPROPORTION; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; ELECTRON MICROSCOPY; FAMILY COUNSELING; GASTROSTOMY; GENE; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC COUNSELING; HEALTH SURVEY; HISTOPATHOLOGY; HUMAN; HYPOTHYROIDISM; MUSCLE BIOPSY; MUSCLE WEAKNESS; MYH7 GENE; MYOPATHY; MYOTONIC DYSTROPHY; NONINVASIVE VENTILATION; OSTEOPOROSIS; PHYSIOTHERAPY; RECURRENCE RISK; RESPIRATORY FAILURE; RYR1 GENE; SPINAL MUSCULAR ATROPHY; TPM2 GENE; TPM3 GENE; TUBE FEEDING;

DIAGNOSIS, DIFFERENTIAL; HUMANS; MALE; MUSCLE FIBERS, SKELETAL; MUTATION; MYOPATHIES, STRUCTURAL, CONGENITAL;

EID: 83455171580     PISSN: 10719091     EISSN: 15580776     Source Type: Journal    
DOI: 10.1016/j.spen.2011.10.008     Document Type: Article

References (44)

1. Clarke N.F. Congenital fibre type disproportion-A syndrome at the crossroads of the congenital myopathies. Neuromuscul Disord 2011, 21:252-253.
2. Brooke M.H., Engel W.K. The histographic analysis of human muscle biopsies with regard to fiber types. 4. Children's biopsies. Neurology 1969, 19:591-605.
3. Brooke M.H. Congenital fiber type disproportion. Clinical Studies in Myology 1973, 147-159. Exerpta Medica, Amsterdam. B.A. Kakulas (Ed.).
4. Dubowitz V. Congenital fibre type disproportion: A pathology in search of a disease. Muscle Disorders of Childhood 1995, 2nd ed.. Baillière Tindall, London. V. Dubowitz (Ed.).
5. Martin J.J., Clara R., Ceuterick C., et al. Is congenital fibre type disproportion a true myopathy?. Acta Neurol Belg 1976, 76:335-344.
6. Fardeau M., Tomé F.M.S. Congenital myopathies. Myology 1994, 1487-1532. McGraw-Hill, New York. http://www.amazon.com/Myology-2-Set-Andrew-Engel/dp/007137180X/ref=sr_1_1?s=books%26ie=UTF8%26qid=1321785979%26sr=1-1, 2nd ed. A.G. Engel, C. Franzini-Armstrong (Eds.).
7. Clarke N.F., Kolski H., Dye D.E., et al. Mutations in TPM3 are a common cause of congenital fiber type disproportion. Ann Neurol 2008, 63:329-337.
8. Sobrido M.J., Fernández J.M., Fontoira E., et al. Autosomal dominant congenital fibre type disproportion: A clinicopathological and imaging study of a large family. Brain 2005, 128:1716-1727.
9. Bove K.E., Iannaccone S.T., Vogler C. Intramuscular hematopoiesis in hypotonic infants with type 1 muscle fiber dysmaturation. Arch Pathol Lab Med 1986, 110:207-211.
10. Iannaccone S.T., Bove K.E., Vogler C.A., et al. Type 1 fiber size disproportion: Morphometric data from 37 children with myopathic, neuropathic, or idiopathic hypotonia. Pediatr Pathol 1987, 7:395-419.
11. Simón R., Mateos F., Seijo M., et al. Congenital fiber-type disproportion: Analysis of a series of 11 cases [in Spanish]. Neurologia 1991, 6:281-286.
12. Schessl J., Goemans N.M., Magold A.I., et al. Predominant fiber atrophy and fiber type disproportion in early Ullrich disease. Muscle Nerve 2008, 38:1184-1191.
13. Lawlor M.W., Dechene E.T., Roumm E., et al. Mutations of tropomyosin 3 (TPM3) are common and associated with type 1 myofiber hypotrophy in congenital fiber type disproportion. Hum Mutat 2009, 31:176-183.
14. Clarke N.F., Waddell L.B., Cooper S.T., et al. Recessive mutations in RYR1 are a common cause of congenital fiber type disproportion. Hum Mutat 2010, 31:E1544-E1550.
15. Laing N.G., Clarke N.F., Dye D.E., et al. Actin mutations are one cause of congenital fibre type disproportion. Ann Neurol 2004, 56:689-694.
16. Ortolano S., Tarrío R., Blanco-Arias P., et al. A novel MYH7 mutation links congenital fiber type disproportion and myosin storage myopathy. Neuromuscul Disord 2011, 21:254-262.
17. Brandis A., Aronica E., Goebel H.H. TPM2 mutation. Neuromuscul Disord 2008, 18:1005.
18. Clarke N.F., Smith R.L., Bahlo M., et al. A novel X-linked form of congenital fibre type disproportion. Ann Neurol 2005, 58:767-772.
19. Imoto C., Nonaka I. The significance of type 1 fiber atrophy (hypotrophy) in childhood neuromuscular disorders. Brain Dev 2001, 23:298-302.
20. Laing N.G., Wilton S.D., Akkari P.A., et al. A mutation in the alpha tropomyosin gene TPM3 associated with autosomal dominant nemaline myopathy. Nat Genet 1995, 9:75-79.
21. Clarke N.F. Skeletal muscle disease due to mutations in tropomyosin, troponin and cofilin. Adv Exp Med Biol 2008, 642:40-54.
22. Ottenheijm C.A., Lawlor M.W., Stienen G.J., et al. Changes in cross-bridge cycling underlie muscle weakness in patients with tropomyosin 3-based myopathy. Hum Mol Genet 2011, 20:2015-2025.
23. Schevzov G., Vrhovski B., Bryce N.S., et al. Tissue-specific tropomyosin isoform composition. J Histochem Cytochem 2005, 53:557-570.
24. Quane K.A., Healy J.M., Keating K.E., et al. Mutations in the ryanodine receptor gene in central core disease and malignant hyperthermia. Nat Genet 1993, 5:51-55.
25. Davis M.R., Haan E., Jungbluth H., et al. Principal mutation hotspot for central core disease and related myopathies in the C-terminal transmembrane region of the RYR1 gene. Neuromuscul Disord 2003, 13:151-157.
26. Jungbluth H., Zhou H., Hartley L., et al. Minicore myopathy with ophthalmoplegia caused by mutations in the ryanodine receptor type 1 gene. Neurology 2005, 65:1930-1935.
27. Wilmshurst J.M., Lillis S., Zhou H., et al. RYR1 mutations are a common cause of congenital myopathies with central nuclei. Ann Neurol 2010, 68:717-726.
28. Jungbluth H., Davis M.R., Müller C., et al. Magnetic resonance imaging of muscle in congenital myopathies associated with RYR1 mutations. Neuromuscul Disord 2004, 14:785-790.
29. Laing N.G., Dye D.E., Wallgren-Pettersson C., et al. Mutations and polymorphisms of the skeletal muscle alpha-actin gene (ACTA1). Hum Mutat 2009, 30:1267-1277.
30. Ryan M.M., Ilkovski B., Strickland C.D., et al. Clinical course correlates poorly with muscle pathology in nemaline myopathy. Neurology 2003, 60:665-673.
31. Clarke N.F., Ilkovski B., Cooper S., et al. The pathogenesis of ACTA1-related congenital fiber type disproportion. Ann Neurol 2007, 61:552-561.
32. Feng J.J., Marston S. Genotype-phenotype correlations in ACTA1 mutations that cause congenital myopathies. Neuromuscul Disord 2009, 19:6-16.
33. Tajsharghi H., Oldfors A., Swash M. Myosin storage myopathy with cardiomyopathy. Neuromuscul Disord 2007, 17:725.
34. Dye D.E., Azzarelli B., Goebel H.H., et al. Novel slow-skeletal myosin (MYH7) mutation in the original myosin storage myopathy kindred. Neuromuscul Disord 2006, 16:357-360.
35. Bohlega S., Lach B., Meyer B.F., et al. Autosomal dominant hyaline body myopathy: Clinical variability and pathologic findings. Neurology 2003, 61:1519-1523.
36. Clarke N.F., Domazetovska A., Waddell L., et al. Cap disease due to mutation of the beta-tropomyosin gene (TPM2). Neuromuscul Disord 2009, 19:348-351.
37. Ferreiro A., Quijano-Roy S., Pichereau C., et al. Mutations of the selenoprotein N gene, which is implicated in rigid spine muscular dystrophy, cause the classical phenotype of multiminicore disease: Reassessing the nosology of early-onset myopathies. Am J Hum Genet 2002, 71:739-749.
38. Moghadaszadeh B., Petit N., Jaillard C., et al. Mutations in SEPN1 cause congenital muscular dystrophy with spinal rigidity and restrictive respiratory syndrome. Nat Genet 2001, 29:17-18.
39. Ferreiro A., Ceuterick-de Groote C., Marks J.J., et al. Desmin-related myopathy with Mallory body-like inclusions is caused by mutations of the selenoprotein N gene. Ann Neurol 2004, 55:676-686.
40. Clarke N.F., Kidson W., Quijano-Roy S., et al. SEPN1: Associated with congenital fiber-type disproportion and insulin resistance. Ann Neurol 2006, 59:546-552.
41. Monnier N., Marty I., Faure J., et al. Null mutations causing depletion of the type 1 ryanodine receptor (RYR1) are commonly associated with recessive structural congenital myopathies with cores. Hum Mutat 2008, 29:670-678.
42. Dowling J.J., Lillis S., Amburgey K., et al. King-Denborough syndrome with and without mutations in the skeletal muscle ryanodine receptor (RYR1) gene. Neuromuscul Disord 2011, 21:420-427.
43. Makri S., Clarke N.F., Richard P., et al. Germinal mosaicism for LMNA mimics autosomal recessive congenital muscular dystrophy. Neuromuscul Disord 2009, 19:26-28.
44. Kuhlenbäumer G., Hullmann J., Appenzeller S. Novel genomic techniques open new avenues in the analysis of monogenic disorders. Hum Mutat 2011, 32:144-151.